NASDAQ:CDTX
Delisted

Cidara Therapeutics Stock Predictions

etoro logo Buy CDTX
*Your capital is at risk
$221.38
+0 (+0%)
At Close: Apr 07, 2026
Currently predicting for Mon, 8 Jun 2026

CDTX Prediction Chart

CDTX Predictions History

Latest community submissions for CDTX.
Predictor Target Session Target Price Result Direction Accuracy Score
May 7, 2025 $20.04 +1.72% $18.98 X 94.42% 0
May 7, 2025 $21.78 +1.30% $18.98 X 85.25% 0
Mar 11, 2025 $23.08 +3.07% $21.00 X 90.11% 0
Mar 11, 2025 $22.82 +1.92% $21.00 X 91.34% 0
Skagitqg Skagitqg Merchant
Mar 11, 2025 Bearish $21.00 V 1
RKP RKP Senior
May 25, 2023 $1.40 -94.78% $1.28 X 90.63% 0
Apr 19, 2023 $1.07 -95.27% $1.12 V 95.47% 1
Apr 19, 2023 $1.09 -95.17% $1.12 V 97.50% 1
Apr 19, 2023 Bullish $1.12 X 0
Apr 3, 2023 $1.18 -95.34% $1.22 V 96.98% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CDTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CIDARA THERAPEUTICS
Cidara Therapeutics
Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE